Québec, Québec
Canada G1J 1Z4
Dernières nouvelles
Information non disponible
- Falardeau, NadineEmployé+1 418-525-4444, poste 65892nadine.falardeau@crchudequebec.ulaval.ca
- Lavoie, SuzyEmployéHôpital de l'Enfant-Jésus+1 418-649-0252, poste 65543+1 418-649-5542+1 418-649-5733Suzy.Lavoie@crchudequebec.ulaval.ca
1401, 18e Rue
Z-252
Québec, Québec
Canada G1J 1Z4
Clinical Predictors of Acute Ischemia in Patients with Low-Risk Neurological Deficits
Article de revueCan J Neurol Sci, 2024.
Derivation of a clinical prediction score for the diagnosis of clinically significant symptomatic carotid artery disease
Article de revueCJEM, 2024.
Quality of Life After Intravenous Thrombolysis for Acute Ischemic Stroke: Results From the AcT Randomized Controlled Trial
Article de revueStroke, 55 (3), 2024.
Apixaban to Prevent Recurrence After Cryptogenic Stroke in Patients With Atrial Cardiopathy: The ARCADIA Randomized Clinical Trial
Article de revueJAMA, 331 (7), 2024.
Mediation of Age and Thrombectomy Outcome by Neuroimaging Markers of Frailty in Patients With Stroke
Article de revueJAMA Netw Open, 7 (1), 2024.
Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial
Article de revueLancet, 403 (10444), 2024.
Time Course of Early Hematoma Expansion in Acute Spot-Sign Positive Intracerebral Hemorrhage: Prespecified Analysis of the SPOTLIGHT Randomized Clinical Trial
Article de revueStroke, 54 (3), 2023.
Prospective Validation of Computed Tomography to Identify Patients at High Risk for Stroke After Transient Ischemic Attack or Minor Stroke
Article de revueStroke, 54 (4), 2023.
Ninety-Day Stroke or Transient Ischemic Attack Recurrence in Patients Prescribed Anticoagulation in the Emergency Department With Atrial Fibrillation and a New Transient Ischemic Attack or Minor Stroke
Article de revueJ Am Heart Assoc, 12 (8), 2023.
Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial
Article de revueLancet, 400 (10347), 2022.